Addex Therapeutics SA Nam.-Aktien SF 1

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

11.70%

Market Cap

4.95 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.07 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.0415 G0 Units
PRICE DETERMINATION TIME07/20/2026 / 09:56:48 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.0420.033
PREV. DAY'S PRICE0.041 (07/17)
CHANGE DAY BEFORE
+0.00
1.22 %
52 WEEK HIGH / LOW0.068 (09/15)0.029 (03/23)
More Price Information

Key Figures (in EUR)

20232024202520262027
EARNINGS PER SHARE
-0.150.08-0.07--
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-0.80---
PRICE - BOOK RATIO
3.830.581.37--
PRICE - SALES RATIO
2.1123.3934.41--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A0MSH6
ISIN
CH0029850754
SYMBOL
APE
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Addex Pharmaceuticals
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Swiss Franc
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
119.32 Mil.
MARKET CAPITALISATION
4.95 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-1.19 %
-7.78 %
-3.49 %
-24.55 %
-11.70 %
--
-3.49 %
HIGH0.040.050.050.060.07--0.06
LOW0.030.030.030.030.03--0.03

Dividende

pro Aktie
Addex Pharmaceuticals does not deliver dividend information

Company profile

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.